Mmm-online - mmm-online.com - Latest articles from Medical Marketing and Media
General Information:
Latest News:
Kyprolis growth prospects at center of Amgen-Onyx deal 26 Aug 2013 | 11:19 pm
Amgen's newest oncology asset could reach great heights, if the firm can capitalize on its existing commercial and R&D capabilities.
AstraZeneca reinforces oncology push 26 Aug 2013 | 09:38 pm
The drug maker is adding Amplimunne's cancer portfolio to subsidiary MedImmune's oncology efforts, one of several recent deals to add heft.
CVS joins prescription crackdown 22 Aug 2013 | 10:55 pm
The drugstore chain says it has cut off over-prescribers of tightly controlled medications.
Takeda may be poised to expand IBS treatment category 22 Aug 2013 | 08:52 pm
Phase III results of its Crohn's and ulcerative colitis medication show positive patient response in a category among patients who have exhausted other options.
Cholesterol market still poised for growth through 2022: study 21 Aug 2013 | 09:45 pm
Despite a gradual loss from generics, new treatments are expected to keep sales trending upward
Analyst gives Merck tough love 21 Aug 2013 | 08:51 pm
Analyst Seamus Fernandez writes that Merck needs to undergo a deep overhaul, continuing the summer narrative that has enveloped Pfizer and Novartis.
Novartis breakthough designation hat trick 20 Aug 2013 | 08:52 pm
The drug maker scored its third breakthrough designation label, this time for orphan drug bimagrumab, a possible treatment for a muscle-wasting disease.
Shire tackles diabetes from the "bottom up" 20 Aug 2013 | 08:49 pm
How Shire's new campaign seeks to help diabetics start off on the right foot
GSK clears another flu vaccine, but patients may not be buying 20 Aug 2013 | 08:02 pm
The FDA approved GlaxoSmithKline's second quadrivalent flu vaccine, but a CVS study indicates that consumers are big fans of the vaccination, as long as they aren't the ones rolling up their sleeves.
NPs, PAs avoiding primary care, while docs glum about independent practices 19 Aug 2013 | 10:06 pm
Researchers say we've been overestimating how many NPs and PAs can be expected to ease the inflow of just-insured patients, while another study shows just why they may be bypassing independent practic...
